Grant to Advance Clinical Utility of Biomarkers in Cancer Care in Arkansas (USA)
GrantID: 69397
Grant Funding Amount Low: $250,000
Deadline: October 14, 2026
Grant Amount High: $250,000
Summary
This grant supports advancing the clinical utility of molecular, cellular, and imaging biomarkers, specifically focusing on cancer detection, diagnosis, prognosis, treatment response prediction, and monitoring. This Notice of Funding Opportunity (NOFO) aims to enhance cancer diagnostics and treatments by fostering the clinical adoption of validated, robust biomarker assays. Through this initiative, researchers can contribute to the development of precision tools that enable more accurate and effective cancer care, ultimately improving patient outcomes and advancing personalized oncology...
Eligible applicants in Arkansas with a demonstrated commitment to Black, Indigenous, People of Color are encouraged to consider this funding opportunity. To identify additional grants aligned with your needs, visit The Grant Portal and utilize the Search Grant tool for tailored results.
Eligible Regions
Interests
Eligible Requirements
Overview
This grant is meant to financially support organizations or entities that focus their efforts on, but not limited to: Black, Indigenous, People of Color, Business & Commerce, Health & Medical, Municipalities, Non-Profit Support Services, Science, Technology Research & Development in Arkansas (USA).